Srinagar, Nov 18: A total of 30 drugs have been listed as substandard and misbranded by the Department of Health and Medical Education this year, according to the official records reviewed by Rising Kashmir.
According to the details available ,in J&K, a total of 30 drugs have been declared as misbranded or having labelling errors in the month of September this year by the Food and Drugs Control Organisation which works under the Health and Medical Education Department.
As per the details, the medicines that have been labelled as misbranded are UTEL 40, DAVAOM-D, ProDO 40 DSR, Cefmycin-O, Ancid-Plus Suspension, YSOFLOX-OZ, Panarzol-DSR, Telsen-AM, Gletus M, Gletus M2, PANTON DSR Capsules, Olmesartan Medoxomil 40 mg & Amlodipine 5 mg Tablets, Olmetus 20, Folic Acid Tablets (JKMSCL Hospital Supply), Pantomac-DSR, Samzol-DSR Capsules, Sulphacon (SHD Supply), Cefpodoxime Proxetil Dispersible, Prozosell-DSR Capsules, Jovail Plus, Jondem-4, Pantomac –DSR, Omimac-D, Flunarin 10 (ESI Supply), Panon-DSR, RebestTM –DSR, Pantolid –DSR, Ciprosafe 4% (Sheep Husbandry Department , J&K), Covatil CV 500 (ESI Supply), Tpulse-40, as per the details.
The information revealed that in the case of one drug, RebestTM –DSR, it was found out that the label of the strip shows two different manufacturing addresses. Furthermore, the colour used in EHG Capsule viz pink is not an approved colour, also titanium dioxide is not shown officially on the label and sunset yellow should have been mentioned as Sunset Yellow FCF. Hence misbranded, reads the official document.
Talking to Rising Kashmir, Joint Drugs Controller J&K, Irfana Ahmad said there are many parameters involved when a drug is declared sub-standard, misbranded or has labelling issues.
“We take action as per the laws and inform people through alerts not to purchase the drugs,” she said.
She said their teams take the samples and once the faults are detected the whole batch series of that particular drug is lifted from the market.
